Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS
暂无分享,去创建一个
Christian A. Ross | Kevin F. Bieniek | Hu Li | L. Petrucelli | M. Murray | D. Dickson | C. Link | M. Baker | R. Rademakers | M. DeTure | V. Belzil | Luc Pregent | M. Prudencio | K. Boylan | T. Gendron | Caroline T. Stetler | P. Desaro | Karen Overstreet | M. van Blitterswijk | R. Batra | R. B. Perkerson | Mary D. Davis | W. C. Lee | Amelia E Piazza-Johnston | Sherri M Biendarra | R. Rademakers | Kevin F Bieniek | L. Pregent | Ranjan Batra
[1] D. Ito,et al. Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS. , 2015, Human molecular genetics.
[2] Zhouteng Tao,et al. Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity. , 2015, Human molecular genetics.
[3] N. Shneider,et al. Antisense Proline-Arginine RAN Dipeptides Linked to C9ORF72-ALS/FTD Form Toxic Nuclear Aggregates that Initiate In Vitro and In Vivo Neuronal Death , 2014, Neuron.
[4] Wei Li,et al. Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3′-UTR landscape across seven tumour types , 2014, Nature Communications.
[5] Chaolin Zhang,et al. Loss of MBNL leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. , 2014, Molecular cell.
[6] M. Mesulam,et al. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers , 2014, Neurobiology of Aging.
[7] S. McKnight,et al. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells , 2014, Science.
[8] O. Hendrich,et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins , 2014, Science.
[9] Kevin F. Bieniek,et al. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress , 2014, Acta Neuropathologica.
[10] J. Hodges,et al. Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum , 2014, PloS one.
[11] M. Mann,et al. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration , 2014, Acta Neuropathologica.
[12] O. Hardiman,et al. Patterns of cerebral and cerebellar white matter degeneration in ALS , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[13] Krishna R. Kalari,et al. MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing , 2014, BMC Bioinformatics.
[14] Stuart A. Wilson,et al. Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions , 2014, Brain : a journal of neurology.
[15] Wei Li,et al. CFIm25 links Alternative Polyadenylation to Glioblastoma Tumor Suppression , 2014, Nature.
[16] Lorne Zinman,et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis , 2014, Nature Neuroscience.
[17] J. Ule,et al. Hexanucleotide Repeats in ALS/FTD Form Length-Dependent RNA Foci, Sequester RNA Binding Proteins, and Are Neurotoxic , 2013, Cell reports.
[18] Gene W. Yeo,et al. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration , 2013, Proceedings of the National Academy of Sciences.
[19] L. Petrucelli,et al. Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion , 2013, Science Translational Medicine.
[20] E. Kremmer,et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins , 2013, Acta Neuropathologica.
[21] Kevin F. Bieniek,et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS , 2013, Acta Neuropathologica.
[22] Nipun A. Mistry,et al. RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention , 2013, Neuron.
[23] Brendan J. Frey,et al. A compendium of RNA-binding motifs for decoding gene regulation , 2013, Nature.
[24] Michael Q. Zhang,et al. OLego: fast and sensitive mapping of spliced mRNA-Seq reads using small seeds , 2013, Nucleic acids research.
[25] E. Kremmer,et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.
[26] Michael Benatar,et al. Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.
[27] Kevin F. Bieniek,et al. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS , 2013, Neuron.
[28] C. Broeckhoven,et al. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations , 2013, Acta Neuropathologica.
[29] Yongsheng Shi,et al. Alternative polyadenylation: new insights from global analyses. , 2012, RNA.
[30] M. Tatsuka,et al. PARP6, a mono(ADP-ribosyl) transferase and a negative regulator of cell proliferation, is involved in colorectal cancer development. , 2012, International journal of oncology.
[31] Rosa Rademakers,et al. How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders? , 2012, Current opinion in neurology.
[32] Damian Szklarczyk,et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..
[33] Jonathan M. Bekisz,et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[34] Nick C Fox,et al. Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions , 2012, Alzheimer's Research & Therapy.
[35] M. Ares,et al. Muscleblind-like 2-Mediated Alternative Splicing in the Developing Brain and Dysregulation in Myotonic Dystrophy , 2012, Neuron.
[36] R. Elkon,et al. The Poly(A)-Binding Protein Nuclear 1 Suppresses Alternative Cleavage and Polyadenylation Sites , 2012, Cell.
[37] H. Hakonarson,et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. , 2012, Human molecular genetics.
[38] David T. Jones,et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72 , 2012, Brain : a journal of neurology.
[39] Gene W. Yeo,et al. Integrative genome‐wide analysis reveals cooperative regulation of alternative splicing by hnRNP proteins , 2012, Cell reports.
[40] T. Ferman,et al. Clinical and neuropathologic heterogeneity of c9FTD/ALS associated with hexanucleotide repeat expansion in C9ORF72 , 2011, Acta Neuropathologica.
[41] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[42] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[43] R. Petersen,et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.
[44] Philip Machanick,et al. MEME-ChIP: motif analysis of large DNA datasets , 2011, Bioinform..
[45] Robert H. Brown,et al. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[46] John Q. Trojanowski,et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS , 2010, Nature.
[47] Dorothea Emig,et al. AltAnalyze and DomainGraph: analyzing and visualizing exon expression data , 2010, Nucleic Acids Res..
[48] L. Petrucelli,et al. Review: Transactive response DNA‐binding protein 43 (TDP‐43): mechanisms of neurodegeneration , 2010, Neuropathology and applied neurobiology.
[49] Davis J. McCarthy,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[50] L. Petrucelli,et al. Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity , 2009, Proceedings of the National Academy of Sciences.
[51] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[52] S. Horvath,et al. WGCNA: an R package for weighted correlation network analysis , 2008, BMC Bioinformatics.
[53] J. Trojanowski,et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. , 2008, Archives of neurology.
[54] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[55] Maria Luisa Gorno-Tempini,et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. , 2008, Archives of neurology.
[56] Michael L. Creech,et al. Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.
[57] Didier Dormont,et al. Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability , 2007, Journal of Neurology, Neurosurgery & Psychiatry.
[58] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[59] S Miyano,et al. Open source clustering software. , 2004, Bioinformatics.
[60] T. Cristofaro,et al. Identification of alternative splicing of spinocerebellar ataxia type 2 gene. , 2001, Gene.
[61] J. Pouysségur,et al. Identification of Alternative Spliced Variants of Human Hypoxia-inducible Factor-1α* , 2000, The Journal of Biological Chemistry.
[62] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[63] M. Hutton,et al. Fibrillogenesis of Tau: Insights from Tau Missense Mutations in FTDP‐17 , 1999, Brain pathology.
[64] B. Brooks,et al. El escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis , 1994, Journal of the Neurological Sciences.
[65] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[66] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[67] Mulder Dw. Clinical limits of amyotrophic lateral sclerosis. , 1982 .
[68] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .